Affy's Q2 Revenues Fall 6 Percent but Beat Estimates; Shares Soar
July 23, 2009
Affy's Q2 Revenues Fall 6 Percent but Beat Estimates; Shares Soar
Second-quarter revenues declined 6 percent year-over-year while a loss in the year-ago period swung to a $7.3 million profit. The firm beat analysts' consensus estimates on both the top and bottom lines.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Affymetrix Blames 12 Percent Q2 Sales Drop on Weak European Performance, Sales Reorganization
July 27, 2010 / BioArray News - DNA Link's Chip-Based Forensic Test Could Help ID Korean War Remains
February 12, 2013 / BioArray News - Despite Genotyping Growth, Expression Decline Leaves Analysts Skeptical of Affy Turnaround
November 6, 2012 / BioArray News - PathGen Joins 'Powered by Affymetrix' Program to Expand Reach of Pathogen Detection Test
August 28, 2012 / BioArray News - Despite Genotyping Growth, Affymetrix's Q3 Sales Fall 5 Percent on Service Slowdown
November 2, 2010 / BioArray News